足場技術の世界市場：2023-2030年

世界の足場技術市場は、予測期間（2023-2030年）に10.2%というかなりのCAGRで成長すると予測されています。臓器移植や再建術の世界の需要の高まりと、3D基板に基づく3Dマトリックスの設計に関する研究開発イニシアチブの増加が、市場の成長を可能にしています。細胞間相互作用、ハイスループットスキャニング、トランスフェクション、細胞遊走アッセイなどの3D培養アッセイはすべてスキャフォールド技術を使用しています。さらに、損傷した臓器や病気の組織の治療に応用される脈管形成や臓器インプラント再生などの組織培養は、足場技術の成長に潜在的な機会を提供します。

セグメント別展望

幹細胞治療、再生医療、組織工学のサブセグメントが足場技術の世界市場でかなりのシェアを占めると予想されます。

用途別では、幹細胞治療、再生医療・組織工学、医薬品開発のサブセグメントが世界の足場技術市場でかなりのシェアを占めると予想されています。足場技術は、再建手術、美容外科手術、腹壁修復、歯周病学、軟部組織腫瘍修復、大腸肛門治療などでますます頻繁に利用されるようになっています。国際美容形成外科学会（ISAPS）によると、2021年に形成外科医が行う手術は全体で19.3％増加し、外科手術は世界で1,280万件以上、非外科手術は1,750万件以上行われるといいます。血液幹細胞の移植は、最もよく知られ、頻繁に行われている幹細胞治療です。血液幹細胞は、免疫系や血液系の疾患の治療や、特定のがんの治療後に血液系を修復するために使用されます。血液幹細胞は、欧州では年間約26,000人の患者の治療に使われています。

さらに、再生医療分野における足場技術の普及に、研究者の関心が高まっています。例えば、2020年11月、ウェイクフォレスト再生医療研究所（WFIRM）の科学者たちは、軟骨再生に使用できるハイブリッド組織構造を発表しました。これは、3Dバイオプリンティング技術を用いて作成されました。その結果、組織開発研究の拡大がセグメント拡大に寄与しています。

地域別展望

世界の足場技術市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されています。中でもアジア太平洋地域は、予測期間中に最も速いCAGRを示すと予想されています。再生医療や幹細胞研究を行う政府機関の存在感が高まっていることが、この地域の市場成長を促進する重要な要因となっています。インドでは、民間と政府機関の両方がこの分野に貢献しており、幹細胞研究のエコシステムが活気に満ちています。例えば、2021年にはインド政府から幹細胞研究活動に対する財政支援が行われる予定です。インド政府は、インド医学研究評議会（ICMR）、バイオテクノロジー省（DBT）、科学技術省（DST）など、様々な省や機関を通じて幹細胞研究に取り組んでいます。さらに、臓器移植の利用に対する国民の意識の高まりや、インドや中国などの国々におけるヘルスケア・インフラへの支出の増加も、この地域の市場拡大に寄与しています。

北米が足場技術の世界市場で大きなシェアを占めると予想

北米は、がんの罹患率の高さ、臓器移植の増加、バイオテクノロジー・製薬企業の拡大が足場技術の需要を促進する主要因となっています。地域全体で研究開発が拡大していることも、地域別市場シェアにさらに貢献しています。例えば、2023年4月、Systemic Bio社は米国テキサス州にハイドロゲル足場製造のための新研究所を開設し、創薬開発を強化するための臓器オンチップ技術の研究開発活動を開始しました。米国ではがんなどの疾病が大きな影響を及ぼしています。がんの診断と治療にはがんの手術が一般的です。手術によってがんの大きさや転移の有無がわかるため、がんのステージを把握するのに役立ちます。2020年、米国で新たにがんと診断された症例は180万6590例と推定されます。最も多いがんは、乳がん、肺がん、気管支がん、前立腺がん、結腸・直腸がん、皮膚の黒色腫、膀胱がん、非ホジキンリンパ腫です。また、Akron Biotech、3D Biotek LLC、Thermo Fisher Scientific Inc.、Molecular Matrix Inc.、Xanofi、Corning Incorporatedなどの大手企業の存在が、この地域の成長を後押ししています。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Thermo Fisher Scientific Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Becton, Dickinson and Company
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Merck Group
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 足場技術の世界市場：タイプ別
  • ハイドロゲル
  • 高分子足場
  • マイクロパターン表面マイクロプレート
  • ナノファイバーベースの足場
• 足場技術の世界市場：疾患タイプ別
  • 整形外科、筋骨格系、脊椎
  • がん
  • 皮膚・内臓
  • 歯科
  • その他（心臓・血管、神経、泌尿器）
• 足場技術の世界市場：用途別
  • 幹細胞治療、再生医療、組織工学
  • 医薬品開発
• 足場技術の世界市場：エンドユーザー別
  • バイオテクノロジーおよび製薬機関
  • 研究機関・研究所
  • 病院・診断センター

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
• その他アジア太平洋地域
• 世界のその他の地域

第6章 企業プロファイル

• 3D Biotek, LLC
• AbbVie Inc.
• Akron Biotech
• Avacta Life Sciences Ltd.
• Avantor, Inc.
• BICO Group
• Corning Inc.
• India Medtronic Pvt Ltd.
• Lonza Group Ltd.
• Molecular Matrix, Inc.
• Nanofiber Solutions, LLC
• NuVasive, Inc.
• PELOBIOTECH GmbH
• REPROCELL
• Vericel Corp.

LIST OF TABLES

• 1. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 2. GLOBAL HYDROGELSSCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 3. GLOBAL POLYMERIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 4. GLOBAL MICROPATTERNEDSURFACE MICROPLATESSCAFFOLD TECHNOLOGYMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 5. GLOBAL NANOFIBER BASED SCAFFOLD TECHNOLOGYMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 6. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
• 7. GLOBAL SCAFFOLD TECHNOLOGY FOR ORTHOPEDICS, MUSCULOSKELETAL, & SPINE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 8. GLOBAL SCAFFOLD TECHNOLOGY FOR CANCERMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 9. GLOBAL SCAFFOLD TECHNOLOGY FOR SKIN & INTEGUMENTARY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 10. GLOBAL SCAFFOLD TECHNOLOGY FOR DENTAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 11. GLOBAL SCAFFOLD TECHNOLOGY FOR OTHER DISEASEMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 12. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 13. GLOBAL SCAFFOLD TECHNOLOGY FOR STEM CELL THERAPY, REGENERATIVE MEDICINE, AND TISSUE ENGINEERINGMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 14. GLOBAL SCAFFOLD TECHNOLOGY FOR DRUG DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 15. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
• 16. GLOBAL SCAFFOLD TECHNOLOGY FOR BIOTECHNOLOGY & PHARMACEUTICAL ORGANIZATIONSMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 17. GLOBAL SCAFFOLD TECHNOLOGY FOR RESEARCH LABORATORIES & INSTITUTESMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 18. GLOBAL SCAFFOLD TECHNOLOGY FOR HOSPITALS & DIAGNOSTIC CENTERSMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 19. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 20. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 21. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 22. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
• 23. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 24. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
• 25. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 26. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 27. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
• 28. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 29. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
• 30. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 31. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 32. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
• 33. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 34. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
• 35. REST OF THE WORLD SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 36. REST OF THE WORLD SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 37. REST OF THE WORLD SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
• 38. REST OF THE WORLD SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 39. REST OF THE WORLD TEST MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022 VS 2030 (%)
• 2. GLOBAL HYDROGELSSCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 3. GLOBAL POLYMERICSCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 4. GLOBAL MICROPATTERNED SURFACE MICROPLATESSCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022 VS 2030 (%)
• 5. GLOBAL NANOFIBER BASEDSCAFFOLD TECHNOLOGYMARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 6. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022 VS 2030 (%)
• 7. GLOBAL SCAFFOLD TECHNOLOGY FOR ORTHOPEDICS, MUSCULOSKELETAL, & SPINE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 8. GLOBAL SCAFFOLD TECHNOLOGY FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 9. GLOBAL SCAFFOLD TECHNOLOGY FOR SKIN & INTEGUMENTARY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 10. GLOBAL SCAFFOLD TECHNOLOGY FOR DENTAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 11. GLOBAL SCAFFOLD TECHNOLOGY FOR OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 12. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022 VS 2030 (%)
• 13. GLOBAL SCAFFOLD TECHNOLOGY FOR STEM CELL THERAPY, REGENERATIVE MEDICINE, TISSUE ENGINEERINGMARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 14. GLOBAL SCAFFOLD TECHNOLOGY FOR DRUG DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 15. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022 VS 2030 (%)
• 16. GLOBAL SCAFFOLD TECHNOLOGY FOR BIOTECHNOLOGY & PHARMACEUTICAL ORGANIZATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 17. GLOBAL SCAFFOLD TECHNOLOGY FORRESEARCH LABORATORIES & INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 18. GLOBAL SCAFFOLD TECHNOLOGY FOR HOSPITALS & DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 19. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 20. US SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
• 21. CANADA SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
• 22. UK SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
• 23. FRANCE SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
• 24. GERMANY SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
• 25. ITALY SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
• 26. SPAIN SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
• 27. REST OF EUROPE SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
• 28. INDIA SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
• 29. CHINA SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
• 30. JAPAN SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
• 31. SOUTH KOREA SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
• 32. REST OF ASIA-PACIFIC SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
• 33. REST OF THEWORLD SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)

Global Scaffold technology Market Size, Share & Trends Analysis Report by Type (Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds),by Disease Type (Orthopedics, Musculoskeletal, & Spine, Cancer, Skin & Integumentary, Dental and Others),by Application (Stem Cell Therapy, Regenerative Medicine,& Tissue Engineering, and Drug Development) and by End-User (Biotechnology & Pharmaceutical Organizations, Research Laboratories & Institutes, Hospitals & Diagnostic Centers)Forecast Period (2023-2030)

The global scaffold technology market is anticipated to grow at a considerable CAGR of 10.2% during the forecast period (2023-2030). The rising demand for organ transplant, reconstruction procedures globally and increase in R&D initiatives on the design of a 3D matrix that is based on 3D substrates is enabling the market growth. 3D culture assays such as cell to cell interactions, high throughput scanning, transfections, and cell migration assays all use scaffold technology. In addition, the tissue culture such as vascularization and organ implant regeneration applied in the treatment of damaged and diseased organs or tissues will further provide potential opportunities for the growth of the scaffold technology

Segmental Outlook

The global scaffold technology market is segmented by the type, disease type, application, and end-user. Based on the type, the market is sub-segmented into hydrogels, polymeric scaffolds, micropatterned surface microplates and nanofiber-based scaffolds. Based on disease type the market is sub-segmented into orthopedics, musculoskeletal, & spine, cancer, skin & integumentary, dental and others. Based on the application, the market is sub-segmented into stem cell therapy, regenerative medicine& tissue engineering, and drug development. Further, based on the end-user, the market is sub-segmented into biotechnology & pharmaceutical organizations, research laboratories & institutes, and hospitals & diagnostic centers. Among the type, the hydrogels sub-segment is anticipated to hold a considerable share of the market owing to technological advancements in microfabrication procedures for hydrogels are anticipated to accelerate the segment growth during the forecast period. Companies are launching new hydrogels for cell transplantation, drug depots, and a barrier against restenosis. For instance, in March, 2021 Bio-Techne Corporation announced the release of Cultrex UltiMatrix Reduced Growth Factor Basement Membrane Extract (RGF BME), an extracellular matrix hydrogel that provides significant performance and consistency benefits for culturing organoids and pluripotent stem cells.

Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering Sub-Segment is Anticipated to Hold a Considerable Share of the Global Scaffold technology Market

Among the application, the stem cell therapy, regenerative medicine & tissue engineering, and drug development sub-segment is expected to hold a considerable share of the global scaffold technology market. Scaffold technology is being utilized increasingly frequently in reconstructive surgeries, aesthetic surgeries, abdominal wall repair, periodontology, soft tissue tumor repair and colorectal treatments. According to the International Society of Aesthetic Plastic Surgery (ISAPS), a 19.3% overall increase in procedures performed by plastic surgeons in 2021 with more than 12.8 million surgical, and 17.5 million non-surgical, procedures performed globally. Transplanting blood stem cells is the most well-known and often used stem cell treatment. It may be used to treat immune system and blood system disorders, as well as to repair the blood system following treatment for certain cancers. Blood stem cells are used to treat around 26,000 patients annually in Europe.

Furthermore, researchers have become increasingly interested in the widespread use of scaffold technologies in the field of regenerative medicine. For instance, in November 2020, Wake Forest Institute for Regenerative Medicine (WFIRM) scientists, introduced a hybrid tissue structure that can be used for cartilage regeneration. It was created with the use of 3D bioprinting technology. As a result, the expanding research into tissue development can be ascribed to segment expansion.

Regional Outlook

The global scaffold technology market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to exhibit fastest CAGR during the forecast period. The growing presence of government organizations that conduct regenerative medicine and stem cell research is a key factor driving the regional market growth. India has a vibrant stem cell research ecosystem, with both private and government institutions contributing to the field. For instance, in 2021 financial assistance for stem cell research activities is being provided by the Indian Government. The Government of India has undertaken stem cell research through various Departments/ Institutions, including the Indian Council of Medical Research (ICMR), Department of Biotechnology (DBT), and Department of Science and Technology (DST). Additionally, increasing public consciousness about the use of organ transplants and increased expenditures in healthcare infrastructure in countries such as India and China also contribute to the regional market's expansion.

North America Expected to Hold Considerable Share in the Global Scaffold technology Market

in the high incidences of cancer, increase in number of organ transplantation, and expansion of biotechnology & pharmaceutical companies is a key factor driving demand for scaffold technology. Growing R&D across the region is further contributing regional market share. For instance, in April 2023, Systemic Bio opened its new lab in Texas, US for hydrogel scaffold manufacturing and research and development activities for organ-on-a-chip technology to enhance drug discovery and development. Disease such as cancer has a major impact in the US. Cancer surgery is a common part of diagnosing and treating cancer. Surgery can show the size of the cancer and whether it has spread, which helps to figure out the cancer's stage. In 2020, an estimated 1,806,590 new cases of cancer were diagnosed in the US. The most common cancers were breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, and non-Hodgkin lymphoma. Additionally due to presence of major companies including Akron Biotech, 3D Biotek LLC, Thermo Fisher Scientific Inc., Molecular Matrix Inc., Xanofi, and Corning Incorporated is propelling the region's growth.

Market Players Outlook

The major companies serving the scaffold technology market include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Lonza Group Ltd., 3D Biotek, LLC, Molecular Matrix, Inc., PELOBIOTECH GmbH, India Medtronic Pvt Ltd., Avacta Life Sciences Ltd., AbbVie, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Evonik and BellaSeno, a developer of 3D-printed absorbable scaffolds, were working together to commercialize innovative 3D-printed scaffolds for bone regeneration. The bone scaffolds are made with Evonik's Resomer polymers and are used for large and complex bone defects. Both companies initially began collaborating in 2019 on scaffolds for chest wall and breast reconstruction.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global scaffold technology market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Thermo Fisher Scientific Inc.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Becton, Dickinson and Company
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Merck Group
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Scaffold Technology Market by Type
  • 4.1.1. Hydrogels
  • 4.1.2. Polymeric Scaffolds
  • 4.1.3. Micropatterned Surface Microplates
  • 4.1.4. Nanofiber Based Scaffolds
• 4.2. Global Scaffold Technology Market by Disease Type
  • 4.2.1. Orthopedics, Musculoskeletal, & Spine
  • 4.2.2. Cancer
  • 4.2.3. Skin & Integumentary
  • 4.2.4. Dental
  • 4.2.5. Others (Cardiology & Vascular, Neurology and Urology)
• 4.3. Global Scaffold Technology Market by Application
  • 4.3.1. Stem Cell Therapy, Regenerative Medicine, Tissue Engineering
  • 4.3.2. Drug Development
• 4.4. Global Scaffold Technology Market by End-User
  • 4.4.1. Biotechnology & Pharmaceutical Organizations
  • 4.4.2. Research Laboratories & Institutes
  • 4.4.3. Hospitals & Diagnostic Centers

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
• 5.4. Rest of Asia-Pacific
• 5.5. Rest of the World

6. Company Profiles

• 6.1. 3D Biotek, LLC
• 6.2. AbbVie Inc.
• 6.3. Akron Biotech
• 6.4. Avacta Life Sciences Ltd.
• 6.5. Avantor, Inc.
• 6.6. BICO Group
• 6.7. Corning Inc.
• 6.8. India Medtronic Pvt Ltd.
• 6.9. Lonza Group Ltd.
• 6.10. Molecular Matrix, Inc.
• 6.11. Nanofiber Solutions, LLC
• 6.12. NuVasive, Inc.
• 6.13. PELOBIOTECH GmbH
• 6.14. REPROCELL
• 6.15. Vericel Corp.